Business
Glucose Health, Inc. Reports Debt-Free Balance Sheet and Previews New Soluble Fiber Brand
Glucose Health, Inc. Reports Debt-Free Balance Sheet and Previews New Soluble Fiber Brand.
About this update from Glucose Health, Inc.
[{"type":"text","content":"\r\n\r\n \r\n \r\n Glucose Health, Inc. Reports Debt-Free Balance Sheet and Previews New Soluble Fiber Brand\r\n \r\n \r\n\r\n\r\nGlucose Health, Inc. Reports Debt-Free Balance Sheet and Previews New Soluble Fiber Brand\r\n\r\n\r\n\r\n\r\n\r\nBENTONVILLE, Ark., Jan. 14, 2026 (GLOBE NEWSWIRE) -- Glucose Health, Inc. (OTC: GLUC), a consumer-health company specializing in soluble-fiber nutrition products for metabolic support, today confirmed it has successfully negotiated a Note Settlement Agreement with Board member, Edmund J. Burke. This note, representing a loan to Glucose Health, in the principal amount of $225,000, was originally initiated by Mr. Burke, in August 2024, to provide operating capital to finance Glucose Health, Inc.’s national expansion of GlucoDown, now available in the diabetic care section at more than 1,000 Walgreens pharmacies nationwide. As a result of Mr. Burke’s shareholder friendly agreement, Glucose Health, Inc. now has a debt-free balance sheet. This development further strengthens the Company’s financial position and paves the way for future capital raises to support strategic growth initiatives – including, among other things, the development of an exciting new soluble fiber brand. Under the terms of the Company’s Note Settlement Agreement with Mr. Burke, approximately $30,000 in interest, that had accrued between August 2024 and December 31, 2025, has been waived by Mr. Burke. The loan’s original $225,000 principal balance, representing a debt obligation of Glucose Health, Inc., has now been converted into 1,800,000 shares of restricted common stock, effectively transforming a former debt obligation into a new equity investment by Mr. Burke. This agreement with Mr. Burke follows a similar shareholder-friendly agreement reached last month with holders of multiple series of the Company’s preferred shares. Those shares, along with their accrued dividends, were converted into common stock at an 85% premium to the then market price of GLUC. Additionally, the agreement includes the voluntary return of warrants originally granted to Mr. Burke under the August 2024 Promissory Note Agreement. These warrants would have allowed him to purchase an additional 2.25 million shares of common stock. Mr. Burke’s forfeiture, pertaining to the exercise of these wa...